OLK

Olink Holding AB ADR
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$3.24B
P/E Ratio
EPS
$-0.27
Beta
0.52
52W High
$0.00
52W Low
$0.00
50-Day MA
$24.51
200-Day MA
$24.02
Dividend Yield
Profit Margin
-19.70%
Forward P/E
185.19
PEG Ratio

About Olink Holding AB ADR

Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology and other institutions focused on life science research. The company is headquartered in Uppsala, Sweden.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$170.89M
Gross Profit (TTM)$94.50M
EBITDA$-43.62M
Operating Margin-86.80%
Return on Equity-7.03%
Return on Assets-6.56%
Revenue/Share (TTM)$1.37
Book Value$3.71
Price-to-Book7.02
Price-to-Sales (TTM)18.98
EV/Revenue18.49
EV/EBITDA-136.85
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)4.70%
Shares Outstanding$124.34M
Float$40.95M
% Insiders66.41%
% Institutions35.23%

Historical Volatility

HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
41.7%

Volatility is currently contracting

Latest News

Verici Dx gains Olink Certified Service Provider status to expand proteomics offering

Verici Dx PLC (AIM:VRCI) has become an Olink Certified Service Provider, allowing the transplant diagnostics company to offer Olink-based proteomics assay services from its CAP-certified and CLIA-accredited laboratory. The certification, part of Thermo Fisher's Life Sciences Solutions network, enables Verici Dx to support biomarker discovery, algorithm development, validation, clinical trials and diagnostic applications for both external clients and its own development pipeline.

Proactive Investors8/11/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OLK and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026